The global infertility treatment market is valued at approximately USD 1.70 billion in 2024 and is projected to reach USD 3.65 billion by 2034, growing at a compound annual growth rate (CAGR) of 7.9% over the next decade. This growth is largely driven by the increasing desire for parenthood, which is fueling demand for infertility treatments worldwide.
Download statistics of this report @ https://www.towardshealthcare.com/download-statistics/5116
Rising Cases of Infertility: Infertility is a global issue, affecting a significant portion of the population. According to the World Health Organization (WHO), approximately 17.5% of people worldwide, or 1 in 6 individuals, experience infertility. This growing prevalence highlights the need for accessible, affordable, and high-quality fertility care.
Improved Healthcare Infrastructure: The ongoing expansion of healthcare infrastructure globally is a key driver of the infertility treatment market, making these services more available and accessible.
Advancements in Technology: Technological innovations are improving infertility treatments, leading to better outcomes, higher success rates, and more precise interventions for patients.
Growing Awareness: Awareness about infertility and available treatments has been increasing, particularly in developing and underdeveloped countries. This has helped boost demand for fertility services.
Artificial intelligence (AI) is transforming the infertility treatment landscape, offering the potential to improve patient outcomes and streamline clinical workflows. AI tools help clinics create personalized treatment plans by analyzing comprehensive data, including genetic, hormonal, and lifestyle information. This precision medicine approach improves the chances of successful pregnancies by tailoring treatments to individual needs.
AI is also enhancing diagnostic accuracy. Machine learning algorithms can process large datasets to identify patterns and predict infertility causes that might be missed by human doctors. This enables earlier and more accurate diagnoses, which lead to more effective treatments.
Moreover, AI is improving lab procedures such as embryo selection and cryopreservation. AI algorithms can assess the quality of embryos with greater precision, increasing the chances of successful implantation. AI also optimizes the storage and retrieval of embryos, reducing the risk of human error.
Overall, the integration of AI in infertility treatments not only enhances clinical outcomes but also improves the patient experience by reducing emotional and financial stress related to long treatment cycles. As these technologies evolve, the infertility treatment market is set to grow significantly, with higher success rates and greater accessibility.
Equipment Segment Dominates: In 2023, the equipment segment was the largest contributor to the infertility treatment market and is expected to grow the fastest during the forecast period. Various types of equipment are used at different stages of infertility treatment, and advancements in technology and ongoing research are driving demand for newer, more efficient equipment. The increasing use of IVF and other fertility procedures further fuels the need for specialized equipment.
Assisted Reproductive Technology (ART) Leads: ART, which involves handling eggs or embryos, was the dominant procedure in the infertility treatment market in 2023. Among ART methods, in vitro fertilization (IVF) is the most common, making up 99% of ART procedures. With over 3 million ART cycles conducted globally each year, IVF is preferred due to its high success rates, thanks to scientific advancements.
Female Infertility Treatment Dominates: Female infertility treatment held the largest market share in 2023. Around 30% of fertility issues stem from female-related causes. Conditions such as ovulation problems and polycystic ovary syndrome (PCOS) contribute to rising demand for female infertility treatments. Women’s desire to conceive and avoid the social stigma of infertility are key drivers behind this market segment.
Fertility Centers Lead the Way: Fertility centers were the top end-user in the global infertility treatment market in 2023. These centers benefit from having specialized professionals, the right infrastructure, and advanced equipment, making them a popular choice for patients seeking treatment. The increasing number of fertility centers and the growing patient base contribute to the segment’s growth.
Our Table of Content (TOC) covers key healthcare market segments, materials, technologies and trends—helping you navigate market shifts and make informed decisions: https://www.towardshealthcare.com/table-of-content/infertility-treatment-market-sizing
Access exclusive insight now @ https://www.towardshealthcare.com/price/5116
We’ve prepared a service to support you. Please feel free to contact us at sales@towardshealthcare.com
Web: https://www.towardshealthcare.com
Visit Dental Specifics: https://www.towardsdental.com
Get the latest insights on industry segmentation with our Annual Membership: Get a Subscription
For Latest Update Follow Us: https://www.linkedin.com/company/towards-healthcare
Azenta Life Sciences and Frenova, a division of Fresenius Medical Care and a leader in renal precision medicine, have announced… Read More
Zenara Pharma Private Limited, a leading Biophore company, has received final approval from the U.S. Food and Drug Administration (FDA)… Read More
Silexion Therapeutics Corp., a global clinical-stage biotech company specializing in RNA interference (RNAi) therapies, has announced outstanding new preclinical data… Read More
Canada and the UK have joined forces in a groundbreaking project aimed at developing next-generation immunotherapies for malignant melanoma, a… Read More
The liquid filtration for pharmaceutical market is rapidly evolving and is poised to generate hundreds of millions in revenue between… Read More
The global ophthalmology devices market is valued at USD 7.51 billion in 2024 and is projected to grow to USD… Read More